Can marijuana save Biden’s reelection campaign?

A cannabis rights activist waves a flag outside the Eisenhower Executive Office Building in Washington, D.C. on Oct. 24, 2022.
A cannabis rights activist waves a flag outside the Eisenhower Executive Office Building in Washington, D.C. on Oct. 24, 2022.
Alejandro Alvarez/Reuters

The Biden administration says it’s high time to reclassify marijuana as a less dangerous drug, and it wants to knock it from Schedule I to Schedule III — meaning it would no longer be grouped with heroin and LSD.

Schedule I drugs are considered those with “no currently accepted medical use and a high potential for abuse,” while Schedule III are defined as drugs “with a moderate to low potential for physical and psychological dependence.”

Reclassifying marijuana won’t legalize it at the federal level, but it would mean that the US government recognizes the potential medical benefits of cannabis for the first time. This could boost access to medical marijuana, make legal weed businesses eligible for tax breaks, and open the door for more research on pot.

The Office of Management and Budget still has to review the move, among other steps, before it becomes a reality. But once finalized, it could help boost President Joe Biden’s approval rating. Polling shows that a majority of Americans, particularly young Americans, support legalizing marijuana. As things stand, 24 states and Washington, DC, have already legalized recreational marijuana.

More from GZERO Media

U.S. President Donald Trump speaks with Democratic Republic of the Congo's Foreign Minister Therese Kayikwamba Wagner and Rwanda's Foreign Minister Olivier Nduhungirehe on June 27, 2025.
REUTERS

On June 27, the Democratic Republic of Congo and Rwanda signed a US-mediated peace accord in Washington, D.C., to end decades of violence in the DRC’s resource-rich Great Lakes region. The agreement commits both nations to cease hostilities, withdraw troops, and to end support for armed groups operating in eastern Congowithin 90 days.

What if the next virus isn’t natural, but deliberately engineered and used as a weapon? As geopolitical tensions rise and biological threats become more complex, health security and life sciences are emerging as critical pillars of national defense. In the premiere episode of “The Ripple Effect: Investing in Life Sciences”, leading experts explore the dual-use nature of biotechnology and the urgent need for international oversight, genetic attribution standards, and robust viral surveillance.

A woman lights a cigarette placed in a placard depicting Hungary's Prime Minister Viktor Orbán, during a demonstration, after the Hungarian parliament passed a law that bans LGBTQ+ communities from holding the annual Pride march and allows a broader constraint on freedom of assembly, in Budapest, Hungary, on March 25, 2025.
REUTERS/Marton Monus

Hungary’s capital will proceed with Saturday’s Pride parade celebrating the LGBTQ+ community, despite the rightwing national government’s recent ban on the event.